Primary Care Clinics in Sainte Genevieve, MO Accepting Medicare
1 Primary Care Clinics found. Showing 1 - 1
 Ste Genevieve Family Health Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 575 Pine Drive, Sainte Genevieve, MO 63670 Phone: 573-883-7424 Fax: 573-883-7426 |
News Archive
Anti-tuberculosis program in South Africa may have inadvertently helped create new strain of XDR TB
In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
USPTO grants HemoShear patent for human cell-based surrogate systems
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Spontaneous brain activity in amygdala higher among combat veterans with PTSD
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or under-react in response to stressful tasks, such as recalling a traumatic event or reacting to a photo of a threatening face.
Glycan binding proteins modify parasite infection in cells of the heart muscle
Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.
Syndax receives European patent allowance for entinostat to treat metastatic breast cancer
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
› Verified 1 days ago